by Paul Winner | Oct 25, 2018 | Migraines
Migraine and tension headaches are often painful, but there are notable differences between them that many people are unaware of. It is important to know what these differences are, as they can be pivotal in deciding to seek out a proper diagnosis and treatment. While...
by Paul Winner | Oct 18, 2018 | Multiple Sclerosis
Multiple Sclerosis (MS) is a progressive inflammatory disease of the central nervous system whereby the body’s immune system attacks nerves and protective nerve fibers (myelin sheath) in the brain and spinal cord. Over time, nerves become damaged and inflamed, which...
by Carl Sadowsky, M.D., FAAN | Oct 9, 2018 | Alzheimer's Disease
Insufficient or poor-quality sleep may increase the risk of developing Alzheimer’s disease, according to a health advisory from the American Academy of Sleep Medicine (AASM). Their advisory is based on the results of epidemiological studies that have shown a possible...
by Paul Winner | Sep 25, 2018 | Migraines
A new small molecule calcitonin gene-related peptide (CGRP) drug in phase 3 clinical trials has shown promising relief of migraine symptoms when administered as an acute single-dose treatment. The migraine drug, Rimegepant, relieved pain and other bothersome migraine...
by Paul Winner | Aug 30, 2018 | Migraines
A large global survey of migraine patients which included over 11,000 respondents from 31 countries found that many migraine sufferers commonly deal with functional impairments at work due to their symptoms. Respondents of the survey had at least four migraine days...
by Carl Sadowsky, M.D., FAAN | Aug 14, 2018 | Alzheimer's Disease
New findings from a meta-analysis of studies involving over 11,000 individuals has strengthened the connection between physical exercise and benefits to cognition. Published in the journal Neurology Clinical Practice, this meta-analysis revealed improvements in...
by Carl Sadowsky, M.D., FAAN | Jul 24, 2018 | Alzheimer's Disease
Depression in older adults may be correlated with memory loss due to accelerated brain aging, according to the findings of a study published earlier this year in the journal Neurology. Based on the results of the study, which involved older adult subjects (mean age of...
by Paul Winner | Jul 5, 2018 | Migraines
Adults with migraine now have an additional preventative treatment option available to them, thanks to a new and unique migraine medication that has been approved by the Food and Drug Administration (FDA). Aimovig (erenumab-aooe) is a novel, first of its kind...
by Paul Winner | Jun 19, 2018 | Migraines
Today, there are a variety of different migraine prevention options which can help ease the lifestyle burdens that migraine sufferers often live with. There are several goals to migraine prevention, such as a lessening of functional impairments and disability,...
by Carl Sadowsky, M.D., FAAN | Jun 10, 2018 | Alzheimer's Disease
A recent study examined whether beta-amyloid growth in cognitively normal older adults who are considered beta-amyloid negative (as opposed to beta-amyloid positive) experience symptoms of cognitive decline. Beta-amyloid is the protein component that forms the amyloid...
